Correction to: CGRP induces migraine-like symptoms in mice during both the active and inactive phases [0.03%]
校正：CGRP在小鼠活跃期和不活跃期均诱导类似偏头痛的症状
Anne-Sophie Wattiez,Olivia J Gaul,Adisa Kuburas et al.
Anne-Sophie Wattiez et al.
Published Erratum
The journal of headache and pain. 2021 Oct 5;22(1):115. DOI:10.1186/s10194-021-01332-5 2021
Psychological predictors of negative treatment outcome with Erenumab in chronic migraine: data from an open label long-term prospective study [0.03%]
Erenumab对慢性偏头痛治疗效果不佳的心理预测因素：来自开放标签长期前瞻性研究的数据
Sara Bottiroli,Roberto De Icco,Gloria Vaghi et al.
Sara Bottiroli et al.
Background: Monoclonal antibodies (mABs) targeting the calcitonin gene-related peptide (CGRP) pathway represent the first disease-specific preventive migraine therapy. Growing evidence suggests that they are effective in ...
Efficacy of galcanezumab in patients with migraine and history of failure to 3-4 preventive medication categories: subgroup analysis from CONQUER study [0.03%]
对3-4类预防性药物耐药的偏头痛患者使用galcanezumab治疗的有效性：CONQUER研究的亚组分析
Rose Okonkwo,Antje Tockhorn-Heidenreich,Chad Stroud et al.
Rose Okonkwo et al.
Background: Chronic migraine (CM) and episodic migraine (EM) are associated with substantial headache-related disability, poor quality of life and global societal burden. In this subgroup analysis from the CONQUER study, ...
Leveraging high-resolution 7-tesla MRI to derive quantitative metrics for the trigeminal nerve and subnuclei of limbic structures in trigeminal neuralgia [0.03%]
利用高分辨率7特斯拉MRI得出三叉神经痛的三叉神经和边缘结构子核的定量指标
Judy Alper,Alan C Seifert,Gaurav Verma et al.
Judy Alper et al.
Background: Trigeminal Neuralgia (TN) is a chronic neurological disease that is strongly associated with neurovascular compression (NVC) of the trigeminal nerve near its root entry zone. The trigeminal nerve at the site o...
CGRP antibody therapy in patients with drug resistant migraine and chronic daily headache: a real-world experience [0.03%]
CGRP抗体治疗药物难治性偏头痛和慢性每日头痛的临床实际经验
Armin Scheffler,Hannah Schenk,Sebastian Wurthmann et al.
Armin Scheffler et al.
Background: Calcitonin gene-related peptide (CGRP) (receptor) antibodies (erenumab, fremanezumab and galcanezumab) are increasingly used in prophylactic treatment of migraine. In the approval studies, severely affected pa...
Osmophobia in primary headache patients: associated symptoms and response to preventive treatments [0.03%]
原发性头痛患者的臭气味恐惧症：相关症状及预防治疗反应
Marianna Delussi,Anna Laporta,Ilaria Fraccalvieri et al.
Marianna Delussi et al.
Background: Osmophobia, is common among primary headaches, with prevalence of migraine. The study aimed to evaluate prevalence and clinical characteristics of patients with osmophobia in a cohort of primary headache patie...
Observational Study
The journal of headache and pain. 2021 Sep 18;22(1):109. DOI:10.1186/s10194-021-01327-2 2021
Efficacy and safety of erenumab in Japanese migraine patients with prior preventive treatment failure or concomitant preventive treatment: subgroup analyses of a phase 3, randomized trial [0.03%]
在预防性治疗失败或同时进行过预防性治疗的日本偏头痛患者中，依瑞那单抗的有效性和安全性：III期随机试验的亚组分析
Koichi Hirata,Fumihiko Sakai,Takao Takeshima et al.
Koichi Hirata et al.
Background: These subgroup analyses of a Phase 3, randomized, double-blind, placebo-controlled study evaluated the efficacy and safety of erenumab 70 mg in Japanese migraine patients with/without prior preventive treatmen...
Delayed headache after COVID-19 vaccination: a red flag for vaccine induced cerebral venous thrombosis [0.03%]
COVID-19疫苗接种后的延迟头痛：提示疫苗诱发的脑静脉血栓形成红色信号
David García-Azorín,Thien Phu Do,Andreas R Gantenbein et al.
David García-Azorín et al.
Background: Headache is a frequent symptom following COVID-19 immunization with a typical onset within days post-vaccination. Cases of cerebral venous thrombosis (CVT) have been reported in adenovirus vector-based COVID-1...
Migraine patients in Germany - need for medical recognition and new preventive treatments: results from the PANORAMA survey [0.03%]
德国的偏头痛患者-需要医学认可和新的预防性治疗：PANORAMA调查的结果
M Koch,Z Katsarava,C Baufeld et al.
M Koch et al.
Background: Migraine is a primary headache disorder characterized by recurrent attacks that may have a significant impact on patients' daily life. Treatment options must often be re-evaluated in light of efficacy, tolerab...
Enhanced functional connectivity between habenula and salience network in medication-overuse headache complicating chronic migraine positions it within the addiction disorders: an ICA-based resting-state fMRI study [0.03%]
药物过量性头痛并发慢性偏头痛的外侧缰核与异常醒觉网络功能连接增强：基于独立成分分析的静息态功能磁共振成像研究
Wei Dai,Enchao Qiu,Yun Chen et al.
Wei Dai et al.
Background: Medication-overuse headache (MOH) is a relatively frequently occurring secondary headache caused by overuse of analgesics and/or acute migraine medications. It is believed that MOH is associated with dependenc...